Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Chinese Patent Office
Johnson and Johnson
Deloitte
Fish and Richardson
Novartis
Mallinckrodt
Julphar
Colorcon
Merck

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,514,529

« Back to Dashboard

Which drugs does patent 6,514,529 protect, and when does it expire?

Patent 6,514,529 protects ZYVOX and is included in one NDA.

Protection for ZYVOX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-six patent family members in thirty-three countries.
Summary for Patent: 6,514,529
Title: Oxazolidinone tablet formulation
Abstract:The present invention provides a compressed tablet of an antibacterial oxazolidinone agent which provides high drug load and excellent bioavailability.
Inventor(s): Yamamoto; Ken (Portage, MI), Lin; Homer (Oak Park, CA)
Assignee: Pharmacia & Upjohn Company (Kalamazoo, MI)
Application Number:09/809,696
Patent Claim Types:
see list of patent claims
Dosage form; Use; Composition; Formulation;

Drugs Protected by US Patent 6,514,529

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Pharmacia And Upjohn ZYVOX linezolid TABLET;ORAL 021130-001 Apr 18, 2000 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Pharmacia And Upjohn ZYVOX linezolid TABLET;ORAL 021130-002 Apr 18, 2000 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,514,529

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Portugal 1265608 ➤ Sign Up
Poland 201686 ➤ Sign Up
Poland 366067 ➤ Sign Up
Peru 11262001 ➤ Sign Up
Peru 04992002 ➤ Sign Up
New Zealand 521525 ➤ Sign Up
Norway 20024505 ➤ Sign Up
Malaysia 136370 ➤ Sign Up
Mexico PA02009316 ➤ Sign Up
South Korea 20070094673 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Express Scripts
Argus Health
Queensland Health
Dow
Baxter
UBS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot